Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

Randomized trial compares interferon alfa-2b + ribavirin to interferon alone for HCV

Jan. 26, 1998

Anti-H. pylori agents from Pfizer

Jan. 23, 1998

Pivotal Zadaxin trial to begin in Japan

Jan. 22, 1998

Combination HCV therapy receives priority classification from FDA

Jan. 21, 1998

Interim Maxamine phase I data reported

Jan. 19, 1998

Vertex researchers report 3-D structure of hepatitis C enzyme

Jan. 19, 1998

Overview of antiviral agents in hepatic disease

Jan. 15, 1998

Novel binding mechanism described for Shin Nippon's H+/K+-ATPase inhibitor

Jan. 12, 1998

New antiulcer agent now available in Japan

Jan. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...